Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis

Summary

Microparticles (MP) are lipid vesicles from platelets, leukocytes and endothelial cells that are involved in early thrombogenesis. We evaluated a detailed time-course analysis of MPs on thrombogenesis and the associated tissue factor (TF) activity in wild-type, in gene-deleted for E- and P-selectins and with high levels of P-selectin expression after the initiation of venous thrombosis in mice.Inferior vena cava (IVC) ligation was performed on C57BL/6 mice (n =191, 59 = wild-type [WT], 55 = gene-deleted for E- and P – selectins [knock-outs, EPKO] and 77 = elevated levels of soluble P-selectin, named Delta Cytoplasmic Tail (ΔCT). Animals were euthanised at various time points to assess MP production, origin and thrombus weight. MPs were re-injected into separate mice at concentrations of 80,000 and 160,000 units, as well as from different ages. In addition, MPs from thrombosed animals were pooled and TF activity quantitated using a chromogenic assay. Thrombus weight correlated negatively with MPs derived from leukocytes, and positively with MPs derived from platelets for WT animals (p<0.05), while MPs from platelets presented a positive correlation to thrombus weight in the WT and EPKO groups (p<0.01). Total MPs correlated negatively with thrombus weight in the ΔCT group (p<0.05). MP re-injections led to greater thrombus weight, while older MP reinjections tended to form larger thrombus than younger. Finally, TF bearing MPs showed a significant correlation to MP concentrations (R=0.99). In conclusion, MPs appear to be an important element in venous thrombogenesis.

Keywords

Venous thrombosis - inflammation - microparticles - plasminogen - tissue factor - tissue factor activity - animal models

• References

• 1 Stewart GJ, Ritchie WGM, Lynch PR. Venous endothelial damage produced by massive sticking and emigration of leukocytes. Am J Pathol 1974; 74: 507-532.
• 2 Virchow R. Gesammelte Abhandlungen zur Wissenschaftlichen Medizin. Frankfurt: A M Von Meidinger Sohn; 1856: 525-530.
• 3 Esmon CT. Inflammation and thrombosis. J Thromb Haemost 2003; 1: 1343-1348.
• 4 Myers DD, Hawley AE, Farris DM. et al. P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg 2003; 38: 1075-1089.
• 5 Gilbert GE, Sims PJ, Wiedmer T. et al. Platelet-derived MPs express high affinity receptors for factor VIII. J Biol Chem 1991; 266: 17261-17268.
• 6 Mesri M, Altieri DC. Endothelial cell activation by leukocyte MPs. J Immunol 1998; 161: 4382-4387.
• 7 Sabatier F, Roux V, Anfosso F. et al. Interaction of endothelial MPs with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 2002; 99: 3962-3970.
• 8 Deregibus MC, Cantaluppi V, Calogero R. et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007; 110: 2440-2448.
• 9 Falati S, Liu Q, Gross P. et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197: 1585-1598.
• 10 Martinez MC, Tesse A, Zobairi F. et al. Shed membrane MPs from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 2005; 288: H1004-H1009.
• 11 Sevinsky JR, Rao LV, Ruf W. Ligand-induced pro-tease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol 1996; 133: 293-304.
• 12 Bullard DC, Qin L, Lorenzo I. et al. P-Selectin/ ICAM-1 double mutant mice: acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. J Clin Invest 1995; 95: 1782-1788.
• 13 Bullard DC, Kunkel EJ, Kubo H. et al. Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J Exp Med 1996; 183: 2329-2336.
• 14 Andre P, Hartwell D, Hrachovinova I. et al. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000; 97: 13835-13840.
• 15 Hartwell DW, Mayadas TN, Berger G. et al. Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses. J Cell Biol 1998; 143: 1129-1141.
• 16 Osterud B. The role of platelets in decrypting monocyte tissue factor. Semin Hematol 2001; 38 4 Suppl 12 2-5.
• 17 Myers Jr DD, Rectenwald JE. et al. Decreased venous thrombosis with an oral inhibitor of P- selectin. J Vasc Surg 2005; 42: 329-336.
• 18 Myers DD, Wakefield TW. Inflammation-dependent thrombosis. Front Biosci 2005; Sep 1 10: 2750-2757.
• 19 Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 2005; 3: 1590-1596.
• 20 Giesen PL, Rauch U, Bohrmann B. et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-2315.
• 21 Jy W, Horstman LL, Wang F. et al. Platelet factor 3 in plasma fractions: its relation to microparticle size and thromboses. Thromb Res 1995; 80: 471-482.
• 22 Hrachovinová I, Cambien B, Hafezi-Moghadam A. et al. Interaction of P-selectin and PSGL-1 generates MPs that correct hemostasis in a mouse model of hemophilia A. Nat Med 2003; 9: 1020-1025.
• 23 Biró E, Sturk-Maquelin KN, Vogel GM. et al. Human cell-derived MPs promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003; 1: 2561-2568.
• 24 Podor TJ, Singh D, Chindemi P. et al. Vimentin exposed on activated platelets and platelet MPs localizes vitronectin and plasminogen activator inhibitor complexes on their surface. J Biol Chem 2002; 277: 7529-7539.
• 25 Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol 2008; 28: 387-391.
• 26 Rectenwald JE, Myers Jr DD, Hawley AE. et al. D-dimer, P-selectin, and MPs: novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost 2005; 94: 1312-1317.
• 27 Chirinos JA, Heresi GA, Velasquez H. et al. Elevation of endothelial MPs, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005; 45: 1467-1471.
• 28 Rauch U, Nemerson Y. Circulating tissue factor and thrombosis. Current Opin Hematol 2000; 7: 273-277.
• 29 Falati S, Liu Q, Gross P. et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197: 1585-1598.